Skip to main content
. 2020 Aug 10;45(6):801–808. doi: 10.1007/s13318-020-00639-z
A single administration of paracetamol increases exposure to sorafenib and sorafenib N-oxide in the brain tissue.
Patients receiving paracetamol during sorafenib therapy may experience intensified adverse reactions from sorafenib.